NanoViricides, Inc. (NASDAQ:NNVC)

BRIEF

published on 09/09/2025 at 14:35, 6 months 10 days ago

NanoViricides présentera un médicament antiviral révolutionnaire au congrès LSX

NanoViricides NV-387 Essai Clinique Médicaments Antiviraux Congrès LSX
BRIEF

published on 09/09/2025 at 14:35, 6 months 10 days ago

NanoViricides to Showcase Revolutionary Antiviral Drug at LSX Congress

NanoViricides NV-387 Antiviral Drugs Clinical Trial LSX Congress
PRESS RELEASE

published on 09/09/2025 at 14:30, 6 months 10 days ago

NanoViricides to Present at the Life Science Executive Partnering (LSX) Congress in Boston on September 17, 2025
NanoViricides, Inc. to showcase revolutionary antiviral drug NV-387 at LSX World Congress 2025 in Boston. Update on drug pipeline and platform technologies by Dr. Diwan

NanoViricides NV-387 Antiviral Drug LSX World Congress Dr. Diwan
BRIEF

published on 08/18/2025 at 14:35, 7 months 1 day ago

NanoViricides annonce l'essai clinique prometteur du médicament antiviral NV-387

NV-387 Essais Cliniques Inflammation Anti-cancer Médicament Antiviral
BRIEF

published on 08/18/2025 at 14:35, 7 months 1 day ago

NanoViricides Reports Promising Antiviral Drug NV-387 in Clinical Trials

NV-387 Clinical Trials Antiviral Drug Inflammation Anti-cancer
PRESS RELEASE

published on 08/18/2025 at 14:30, 7 months 1 day ago

A Drug that Could Reduce Metastatic Cancer Resurgence due to Its Anti-Inflammatory Effects in Viral Infections is in Clinical Trials
NanoViricides, Inc. reports NV-387 antiviral drug could reduce metastatic cancer resurgence caused by viral infections. NV-387 completed Phase I trial, advancing to Phase II

NV-387 NanoViricides Inc. Antiviral Drug Viral Infections Metastatic Cancer
BRIEF

published on 07/30/2025 at 14:35, 7 months 20 days ago

NanoViricides présente le NV-387 comme une solution clé contre la rougeole face à l'augmentation des cas

Désignation De Médicament Orphelin Médicament NV-387 Augmentation De La Rougeole Vaccination Mondiale Risque Pour La Santé Publique
BRIEF

published on 07/30/2025 at 14:35, 7 months 20 days ago

NanoViricides Highlights NV-387 as Key Measles Solution Amid Rising Cases

Orphan Drug Designation NV-387 Drug Measles Increase Global Vaccination Public Health Risk
PRESS RELEASE

published on 07/30/2025 at 14:30, 7 months 20 days ago

Measles Cases Increasing Worldwide, Need the New NV-387 Broad-Spectrum Antiviral to Combat, Says NanoViricides
NanoViricides introduces drug candidate NV-387 as a potential treatment for Measles outbreak. The drug has shown safety and effectiveness in animal studies and Phase I trial, aiming to combat the global epidemic

NanoViricides NV-387 Antiviral Vaccination Measles
BRIEF

published on 07/23/2025 at 14:35, 7 months 27 days ago

NanoViricides Explores Potential of Broad-Spectrum Antiviral NV-387

NV-387 Regulatory Approval Broad-spectrum Antiviral Pandemic Preparedness Orphan Drug Status

Published on 03/20/2026 at 03:10, 2 hours 56 minutes ago

Future Fuels Announces Filing of Amended and Restated Life Offering Document
Published on 03/20/2026 at 00:20, 5 hours 46 minutes ago

Prospect Ridge To Host Investor Webinar With Presentation And Audience Q&A
Published on 03/20/2026 at 00:20, 5 hours 46 minutes ago

Reeflex Solutions Inc. Announces Revocation of Management Cease Trade Order
Published on 03/19/2026 at 21:16, 8 hours 50 minutes ago

Unusual Machines, Inc. Announces Proposed Public Offering
Published on 03/19/2026 at 14:20, 15 hours 46 minutes ago

CBMJ CEO Rips Legacy Liberal Media Over Iran Coverage on The Schaftlein Report

View all ACCESSWIRE

Published on 03/20/2026 at 03:05, 3 hours ago

HEROAD Unleashes a New Era of Gaming: Professional-Grade Gear Meets Unbeatable Value
Published on 03/19/2026 at 23:48, 6 hours 17 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3C daily buy back notice
Published on 03/19/2026 at 22:55, 7 hours 10 minutes ago

Baristas behind millions of cups of coffee compete globally
Published on 03/19/2026 at 22:48, 7 hours 17 minutes ago

EQS-Adhoc: Forecast for the 2026 financial year
Published on 03/19/2026 at 19:30, 10 hours 36 minutes ago

EEII AG: Publication of Listing Prospectus

View all EQS

Published on 03/19/2026 at 18:00, 12 hours 6 minutes ago

Filing of the 2025 Universal Registration Document
Published on 03/19/2026 at 18:00, 12 hours 6 minutes ago

Mise à disposition du Document d’Enregistrement Universel 2025
Published on 03/19/2026 at 15:00, 15 hours 6 minutes ago

Statement Accor
Published on 03/19/2026 at 15:00, 15 hours 6 minutes ago

Communication Accor
Published on 03/19/2026 at 08:45, 21 hours 21 minutes ago

Deezer et Sonos renouvellent et étendent leur partenariat stratégique

View all LES ECHOS COMFI WIRE

News